Literature DB >> 23934153

Structure of the p300 catalytic core and implications for chromatin targeting and HAT regulation.

Manuela Delvecchio1, Jonathan Gaucher, Carmen Aguilar-Gurrieri, Esther Ortega, Daniel Panne.   

Abstract

CBP and p300 are histone acetyltransferases (HATs) that associate with and acetylate transcriptional regulators and chromatin. Mutations in their catalytic 'cores' are linked to genetic disorders, including cancer. Here we present the 2.8-Å crystal structure of the catalytic core of human p300 containing its bromodomain, CH2 region and HAT domain. The structure reveals that the CH2 region contains a discontinuous PHD domain interrupted by a RING domain. The bromodomain, PHD, RING and HAT domains adopt an assembled configuration with the RING domain positioned over the HAT substrate-binding pocket. Disease mutations that disrupt RING attachment led to upregulation of HAT activity, thus revealing an inhibitory role for this domain. The structure provides a starting point for understanding how chromatin-substrate targeting and HAT regulation are coupled and why mutations in the p300 core lead to dysregulation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23934153     DOI: 10.1038/nsmb.2642

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  36 in total

Review 1.  CBP/p300 in cell growth, transformation, and development.

Authors:  R H Goodman; S Smolik
Journal:  Genes Dev       Date:  2000-07-01       Impact factor: 11.361

2.  Nucleosome sliding via TBP DNA binding in vivo.

Authors:  S Lomvardas; D Thanos
Journal:  Cell       Date:  2001-09-21       Impact factor: 41.582

3.  c-Myb acetylation at the carboxyl-terminal conserved domain by transcriptional co-activator p300.

Authors:  A Tomita; M Towatari; S Tsuzuki; F Hayakawa; H Kosugi; K Tamai; T Miyazaki; T Kinoshita; H Saito
Journal:  Oncogene       Date:  2000-01-20       Impact factor: 9.867

4.  Mutations truncating the EP300 acetylase in human cancers.

Authors:  S A Gayther; S J Batley; L Linger; A Bannister; K Thorpe; S F Chin; Y Daigo; P Russell; A Wilson; H M Sowter; J D Delhanty; B A Ponder; T Kouzarides; C Caldas
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

Review 5.  Multivalent engagement of chromatin modifications by linked binding modules.

Authors:  Alexander J Ruthenburg; Haitao Li; Dinshaw J Patel; C David Allis
Journal:  Nat Rev Mol Cell Biol       Date:  2007-12       Impact factor: 94.444

6.  Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription.

Authors:  M Merika; A J Williams; G Chen; T Collins; D Thanos
Journal:  Mol Cell       Date:  1998-01       Impact factor: 17.970

7.  Recognition of a mononucleosomal histone modification pattern by BPTF via multivalent interactions.

Authors:  Alexander J Ruthenburg; Haitao Li; Thomas A Milne; Scott Dewell; Robert K McGinty; Melanie Yuen; Beatrix Ueberheide; Yali Dou; Tom W Muir; Dinshaw J Patel; C David Allis
Journal:  Cell       Date:  2011-05-19       Impact factor: 41.582

Review 8.  CBP and p300: HATs for different occasions.

Authors:  Eric Kalkhoven
Journal:  Biochem Pharmacol       Date:  2004-09-15       Impact factor: 5.858

9.  Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation.

Authors:  Shiraz Mujtaba; Yan He; Lei Zeng; Sherry Yan; Olga Plotnikova; Roberto Sanchez; Nancy J Zeleznik-Le; Ze'ev Ronai; Ming-Ming Zhou
Journal:  Mol Cell       Date:  2004-01-30       Impact factor: 17.970

10.  Inactivating mutations of acetyltransferase genes in B-cell lymphoma.

Authors:  Laura Pasqualucci; David Dominguez-Sola; Annalisa Chiarenza; Giulia Fabbri; Adina Grunn; Vladimir Trifonov; Lawryn H Kasper; Stephanie Lerach; Hongyan Tang; Jing Ma; Davide Rossi; Amy Chadburn; Vundavalli V Murty; Charles G Mullighan; Gianluca Gaidano; Raul Rabadan; Paul K Brindle; Riccardo Dalla-Favera
Journal:  Nature       Date:  2011-03-10       Impact factor: 49.962

View more
  89 in total

1.  Uncovering Phosphorylation-Based Specificities through Functional Interaction Networks.

Authors:  Omar Wagih; Naoyuki Sugiyama; Yasushi Ishihama; Pedro Beltrao
Journal:  Mol Cell Proteomics       Date:  2015-11-16       Impact factor: 5.911

2.  RNA Binding to CBP Stimulates Histone Acetylation and Transcription.

Authors:  Daniel A Bose; Greg Donahue; Danny Reinberg; Ramin Shiekhattar; Roberto Bonasio; Shelley L Berger
Journal:  Cell       Date:  2017-01-12       Impact factor: 41.582

3.  Role of the CBP catalytic core in intramolecular SUMOylation and control of histone H3 acetylation.

Authors:  Sangho Park; Robyn L Stanfield; Maria A Martinez-Yamout; H Jane Dyson; Ian A Wilson; Peter E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

Review 4.  Roles of Grainyhead-like transcription factors in cancer.

Authors:  S M Frisch; J C Farris; P M Pifer
Journal:  Oncogene       Date:  2017-07-17       Impact factor: 9.867

Review 5.  An evolving understanding of nuclear receptor coregulator proteins.

Authors:  Christopher J Millard; Peter J Watson; Louise Fairall; John W R Schwabe
Journal:  J Mol Endocrinol       Date:  2013-11-07       Impact factor: 5.098

6.  A novel recurrent EP300-ZNF384 gene fusion in B-cell precursor acute lymphoblastic leukemia.

Authors:  Y Gocho; N Kiyokawa; H Ichikawa; K Nakabayashi; T Osumi; T Ishibashi; H Ueno; K Terada; K Oboki; H Sakamoto; Y Shioda; M Imai; Y Noguchi; Y Arakawa; Y Kojima; D Toyama; K Hata; T Yoshida; K Matsumoto; M Kato; T Fukushima; K Koh; A Manabe; A Ohara
Journal:  Leukemia       Date:  2015-05-06       Impact factor: 11.528

Review 7.  Protein lysine acetylation by p300/CBP.

Authors:  Beverley M Dancy; Philip A Cole
Journal:  Chem Rev       Date:  2015-01-16       Impact factor: 60.622

8.  Combination Targeting of the Bromodomain and Acetyltransferase Active Site of p300/CBP.

Authors:  Beth E Zucconi; Jessica L Makofske; David J Meyers; Yousang Hwang; Mingxuan Wu; Mitzi I Kuroda; Philip A Cole
Journal:  Biochemistry       Date:  2019-04-11       Impact factor: 3.162

9.  JQ1, a bromodomain inhibitor, suppresses Th17 effectors by blocking p300-mediated acetylation of RORγt.

Authors:  Xiunan Wang; Yan Yang; Dandan Ren; Yuanyuan Xia; Wenguang He; Qingsi Wu; Junling Zhang; Miao Liu; Yinan Du; Cuiping Ren; Bin Li; Jijia Shen; Yuxia Zhang
Journal:  Br J Pharmacol       Date:  2020-03-23       Impact factor: 8.739

10.  Catalytic mechanism of histone acetyltransferase p300: from the proton transfer to acetylation reaction.

Authors:  Xinlei Zhang; Sisheng Ouyang; Xiangqian Kong; Zhongjie Liang; Junyan Lu; Kongkai Zhu; Dan Zhao; Mingyue Zheng; Hualiang Jiang; Xin Liu; Ronen Marmorstein; Cheng Luo
Journal:  J Phys Chem B       Date:  2014-02-19       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.